Benjamin Remo, MD
Clinical Cardiac Electrophysiology · Easton, MDNPI 1376785717
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (39.7%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Boston Scientific at 51.5% of the total. 2025 is the largest year on record at $8,402, 4.1 times the $2,044 reported in 2019.
Across 180 payments — averaging $110.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$10K
- Medtronic$5K
- Abbott$3K
- Biosense Webster, Inc.$534
- Medical Device Business Services, Inc.$249
- Irhythm Technologies, Inc.$133
- plus $421 from 12 others
What the payments were for
- Speaking & faculty fees$5,00025%
- Travel & lodging$6,94635%
- Food & beverage$7,88640%
- Education$280%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 43 | $10,219 |
| Medtronic(2 entities) | 59 | $5,028 |
| Abbott | 42 | $3,275 |
| Biosense Webster, Inc. | 8 | $534 |
| Medical Device Business Services, Inc. | 1 | $249 |
| Irhythm Technologies, Inc. | 8 | $133 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $105 |
| Cvrx, Inc. | 1 | $77 |
| E.r. Squibb & Sons, L.L.C. | 2 | $43 |
| Cardiva Medical, Inc. | 2 | $40 |
| Pfizer | 3 | $38 |
| Baxter Healthcare | 1 | $19 |
| Boehringer Ingelheim | 1 | $19 |
| Amgen | 1 | $18 |
| Elutia, Inc. | 1 | $17 |
| Itamar Medical Inc | 1 | $17 |
| Novartis | 1 | $16 |
| AstraZeneca | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WATCHMAN Access System$7,828
- Micra$1,814
- AVEIR$1,564
- EMBLEM MRI S-ICD$937
- Carto 3$522
- COBALT DR MRI SURESCAN$347
- SelectSecure$271
- LUX-Dx Insertable Cardiac Monitor$257
- LINQ II$245
- Ensite Cardiac Mapping System$235
- ACCOLADE SR$161
- Assurity Pacemaker$131
- JOT DX$118
- SureScan$115
- ENSITE$114
- HeartWare HVAD$103
How this compares
$19,860 in reported general payments places this provider in the 60th percentile of 63 clinical cardiac electrophysiology providers in Maryland.
See all clinical cardiac electrophysiology providers in Maryland →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 400 | $470,619 |
| XareltoRivaroxaban | 107 | $132,316 |
| EntrestoSacubitril/Valsartan | 74 | $93,349 |
| FarxigaDapagliflozin Propanediol | 41 | $44,493 |
| Metoprolol Succinate | 607 | $9,858 |
| Flecainide Acetate | 182 | $6,237 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 95 | $3,620 |
| Dofetilide | 22 | $1,997 |
| Levalbuterol Tartrate HfaLevalbuterol Tartrate | 40 | $1,959 |
| Atorvastatin Calcium | 126 | $1,718 |
| Rosuvastatin Calcium | 101 | $1,437 |
| Carvedilol | 102 | $1,150 |
| Amiodarone Hcl | 59 | $1,079 |
| Lisinopril | 82 | $910 |
| ClopidogrelClopidogrel Bisulfate | 49 | $868 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $38 | $470,619400 claims |
| NovartisEntresto | $16 | $93,34974 claims |
| AstraZenecaFarxiga | $13 | $44,49341 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 63 clinical cardiac electrophysiology providers in Maryland.
Other clinical cardiac electrophysiology in Easton
- Sean BeinartRockville$315K
- Charles LoveBaltimore$238K
- Hugh CalkinsBaltimore$202K
- Paresh ShahBaltimore$97K
- Helen BaroldRockville$83K
- Jonathan ChrispinBaltimore$77K
- Sung LeeTakoma Park$68K
- Stephen ShorofskyBaltimore$63K
- Nilofar IslamTowson$61K
- Arooge TowheedLargo$60K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.